article Open AccessTop 1% cited
Revising the definition of Alzheimer's disease: a new lexicon
The Lancet Neurology · 2010 · Vol. 9(11) · pp. 1118–1127
Bruno Dubois✉(Sorbonne Université)Howard Feldman(Bristol-Myers Squibb (United States))Claudia Jacova(University of British Columbia)Jeffrey L. Cummings(Foundation for Psychocultural Research)Steven T. DeKosky(University of Virginia)Pascale Barberger‐Gateau(Inserm)André Delacourte(Laboratoire de Neurosciences Cognitives)Giovanni B. Frisoni(Centro San Giovanni di Dio Fatebenefratelli)Nick C. Fox(University College London)Douglas Galasko(University of California San Diego)Serge Gauthier(Douglas Mental Health University Institute)Harald Hampel(Goethe University Frankfurt)Gregory A. Jicha(University of Kentucky)Kenichi Meguro(Tohoku University)John T. O’Brien(Newcastle University)Florence Pasquier(Centre Hospitalier Universitaire de Lille)Philippe Robert(Université Côte d'Azur)Martin N. Rossor(UK Dementia Research Institute)Steven Salloway(Brown University)Marie Sarazin(Sorbonne Université)Leonardo Cruz de Souza(Sorbonne Université)Yaakov Stern(Presbyterian Hospital)Pieter Jelle Visser(Maastricht University Medical Centre)Philip Scheltens(Amsterdam UMC Location Vrije Universiteit Amsterdam)
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchCholinesterase and Neurodegenerative DiseasesLexiconDementiaDiseaseAlzheimer's diseaseMedicineCornerstonePsychologyIntensive care medicinePathologyComputer science
MeSH terms
Alzheimer DiseaseChicagoDementiaHumansBiomarkers
Funding
- Eisai
Citations
1,837
FWCI
100.48
field-weighted impact
References
94
Percentile
100%
vs. same field & year
Citations per year
Cited by
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
Neurology · 2016 · 1,813 citations
Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease
Oncotarget · 2015 · 547 citations
Defeating Alzheimer's disease and other dementias: a priority for European science and society
The Lancet Neurology · 2016 · 1,667 citations
Resting state fMRI in Alzheimer's disease: beyond the default mode network
Neurobiology of Aging · 2011 · 569 citations
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
The Lancet Neurology · 2013 · 2,242 citations
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
The Lancet Neurology · 2014 · 3,256 citations
Impact of multiple pathologies on the threshold for clinically overt dementia
Acta Neuropathologica · 2017 · 689 citations
References
Tangles and plaques in nondemented aging and ?preclinical? Alzheimer's disease
Annals of Neurology · 1999 · 1,682 citations
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ <sub>42</sub> in humans
Annals of Neurology · 2005 · 1,247 citations
Global prevalence of dementia: a Delphi consensus study
The Lancet · 2005 · 5,309 citations
Neuropathological stageing of Alzheimer-related changes
Acta Neuropathologica · 1991 · 16,076 citations
Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
Archives of Neurology · 2009 · 892 citations
Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
Archives of Neurology · 2008 · 1,046 citations
Diagnosis and management of dementia with Lewy bodies
Neurology · 2005 · 5,038 citations
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
The Lancet Neurology · 2007 · 4,360 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.